Ultragenyx Pharmaceutical (RARE) Capital Expenditures Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -138.04% |
| Sep 30, 2025 | -78.48% |
| Jun 30, 2025 | 830.71% |
| Mar 31, 2025 | -21.88% |
| Dec 31, 2024 | 100.50% |
| Sep 30, 2024 | -83.78% |
| Jun 30, 2024 | 87.61% |
| Mar 31, 2024 | -85.99% |
| Dec 31, 2023 | -1,221.48% |
| Sep 30, 2023 | 1,516.56% |
| Jun 30, 2023 | -74.36% |
| Mar 31, 2023 | -63.13% |
| Dec 31, 2022 | -115.40% |
| Sep 30, 2022 | -112.57% |
| Jun 30, 2022 | -108.78% |
| Mar 31, 2022 | 50.98% |
| Dec 31, 2021 | -26.88% |
| Sep 30, 2021 | 443.92% |
| Jun 30, 2021 | 391.57% |
| Mar 31, 2021 | 16.44% |
| Dec 31, 2020 | 90.83% |
| Sep 30, 2020 | -24.90% |
| Jun 30, 2020 | -22.08% |
| Mar 31, 2020 | 360.80% |
| Dec 31, 2019 | 864.77% |
| Sep 30, 2019 | 387.69% |
| Jun 30, 2019 | 280.54% |
| Mar 31, 2019 | 544.00% |
| Dec 31, 2018 | 179.79% |
| Sep 30, 2018 | -0.10% |
| Jun 30, 2018 | 266.22% |
| Mar 31, 2018 | -2.06% |
| Dec 31, 2017 | 84.06% |
| Sep 30, 2017 | -65.58% |
| Jun 30, 2017 | -92.55% |
| Mar 31, 2017 | -67.16% |
| Dec 31, 2016 | -587.52% |
| Sep 30, 2016 | 51.72% |
| Jun 30, 2016 | 747.73% |
| Mar 31, 2016 | 221.79% |
| Dec 31, 2015 | 232.35% |
| Sep 30, 2015 | 31.60% |
| Jun 30, 2015 | 258.24% |
| Mar 31, 2015 | -19.33% |
| Dec 31, 2014 | -1,226.36% |
| Sep 30, 2014 | 640.39% |
| Jun 30, 2014 | -268.63% |
| Mar 31, 2014 | 221.47% |